Top Sector Life Sciences & Health (LSH) entails a broad scope of disciplines, from pharmaceuticals to medical technology and from healthcare infrastructure to vaccination. To realise its mission – vital citizens in a healthy economy - the Top Sector builds on the strengths of the Dutch LSH sector to address the biggest societal challenges in prevention, cure and care. By funding multidisciplinary public-private partnerships (PPPs) the Top Sector aims to facilitate innovation. Here we give an overview of  a number of funded R&D projects by Top Sector LSH. The page is updated continuously.

Can seaweed reduce blood glucose of obese type 2 diabetes patients?

Potential of seaweed in reducing blood glucose of obese type 2 diabetes patients

The aim of this innovative project is to investigate if dietary supplementation with seaweed improves blood glucose regulation in obese type 2 diabetes patients. The elaborate knowledge of Ocean University of China regarding health-improving components of seaweeds will help the Erasmus MC to obtain insight into the potential beneficial effects of seaweeds from the Eastern Scheldt harvested and processed by Seaweed Harvest Holland and Stichting Zeeschelp on the progression of type 2 diabetes of. After the data have provided scientific evidence for the application of seaweed in the prevention, treatment or reversal of type 2 diabetes Medical Meals will develop a strategy to bring the seaweed-food concept to the attention of companies and will develop “medical-food-boxes” containing locally collected or cultivated seaweed as cost-effective nutrient.

Type 2 diabetes is a serious highly prevalent (> 1 million in the Netherlands) chronic disease and its complications, cardiovascular disease, retinopathy, nephropathy, neuropathy, and foot amputation lead to premature death. Therefore there is an urge for prevention. Because diet plays an important role in the development of type 2 diabetes, the researchers use dietary interventions as a strategy for finding solutions. Seaweeds contain unique bioactive components that improve glucose tolerance and also reduce circulating lipid levels. Consequently, dietary supplementation with seaweed may reduce the risk of complications of type 2 diabetes.

The results will provide scientific evidence for the application of seaweed in the prevention, treatment or even reversal of type 2 diabetes. The final step is to bring locally collected or cultivated seaweed to the market as cost-effective nutrient. Seaweed components can be further examined for pharmacological applications.